Linker Pharmaceuticals ApS — Credit Rating and Financial Key Figures
CVR number: 44308622
Amaliegade 13, 1256 København K
kpj@cortris.com
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | -12.72 |
| EBIT | -12.72 |
| Other financial income | 0.14 |
| Other financial expenses | -1.94 |
| Pre-tax profit | -14.52 |
| Income taxes | 3.19 |
| Net earnings | -11.32 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current deferred tax assets | 3.19 |
| Short term receivables total | 3.19 |
| Cash and bank deposits | 316.23 |
| Cash and cash equivalents | 316.23 |
| Balance sheet total (assets) | 319.43 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Retained earnings | 280.00 |
| Profit of the financial year | -11.32 |
| Shareholders equity total | 308.68 |
| Non-current liabilities total | |
| Current trade creditors | 10.75 |
| Current liabilities total | 10.75 |
| Balance sheet total (liabilities) | 319.43 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.